Harnessing the power of the immune system to treat cancer and other diseases

Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.

Leadership

Stewart Abbot, Ph.D.

SVP and Chief Scientific Officer

Ann Altmeyer photo

Anne Altmeyer, Ph.D.

Chief Business Officer

Brian Hogan

Chief Financial Officer

Carrie Krehlik photo

Carrie Krehlik

Chief Human Resource Officer

Anat Nursella photo

Anat Nursella

SVP, General Manager, Adicet Bio Israel

Elizabeth Read photo

Elizabeth Read, M.D.

SVP, Chief Technology Officer

Donald J. Santel

Executive Chairman of the Board and Interim Chief Executive Officer

Board of Directors

Erez Chimovits

Director

Florent Gros

Director

Aya Jakobovits, Ph.D.

Founder, Director, Senior Strategic Advisor

Donald J. Santel

Executive Chairman of the Board and Interim Chief Executive Officer